Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$73.2K Hold
208
0.01% 245
2025
Q4
$68.1K Sell
208
-8
-4% -$2.54K ﹤0.01% 241
2025
Q3
$61K Buy
216
+16
+8% +$4.64K ﹤0.01% 290
2025
Q2
$55.8K Hold
200
﹤0.01% 247
2025
Q1
$62.3K Hold
200
0.01% 225
2024
Q4
$52.1K Hold
200
﹤0.01% 222
2024
Q3
$64.4K Hold
200
﹤0.01% 198
2024
Q2
$62.5K Hold
200
﹤0.01% 195
2024
Q1
$56.9K Hold
200
﹤0.01% 213
2023
Q4
$57.6K Hold
200
0.01% 200
2023
Q3
$53.8K Sell
200
-130
-39% -$32.4K 0.01% 186
2023
Q2
$73.3K Sell
330
-50
-13% -$11.6K 0.01% 177
2023
Q1
$91.9K Buy
+380
New +$93.3K 0.01% 158

Other funds holding AMGN

Avalon Trust's AMGN Position: Q1 2026 in Review

Avalon Trust held its Amgen (AMGN) position steady in Q1 2026 at 208 shares worth $73.2K. The position accounts for 0.01% of the portfolio, ranked #245.

Avalon Trust first reported a position in AMGN in Q1 2023 and has held it in 13 quarters since. The position peaked at $91.9K in Q1 2023. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Avalon Trust held 208 shares of Amgen worth $73.2K as of Q1 2026.
  • Avalon Trust left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.01% of Avalon Trust's portfolio in Q1 2026, its #245 holding.
  • Avalon Trust first reported a position in Amgen in Q1 2023 and has held it in 13 quarters since.
  • Avalon Trust's Amgen position peaked at $91.9K in Q1 2023.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Avalon Trust's 13F filing for Q1 2026, filed 6 May 2026.